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Objectives: 1. To determine human epidermal growth-factor receptor  (HER2) 
protein-overexpression frequency in patients operated for gastric carcinoma in an 
Indian population. 
 
2. To determine the correlation of HER-2 positivity with pathological findings and 
other factors.  
 
 
 
Methods: 53 patients who underwent gastrectomy for carcinoma stomach were tested 
for HER2 positivity in the resected specimen. Representative tissue bits from the 
tumor were collected and processed. The processed tissue was tested using 
immunohistochemistry (IHC) on a Ventana Benchmark-XT fully automated machine.  
  
Results: From the data that was collected, HER2 was positivity was seen in at least 4 
of the 53 g astrectomy specimens amounting to a prevalence of 7.5%. A further 11% 
of the cases were equivocal for HER2 positivity and would have required additional 
testing (FISH, SISH) to confirm or deny HER2 positivity. Due to cost constraints, this 
could not be done.  This study has shown the positivity of HER2 overexpression 
among patients diagnosed with gastric cancer and underwent surgical resection to be 
in the range of 7.5 to 18 %. Most of the literature on this topic pegs the rate between 
7% - 34% and our study confirms the rate of HER2 positivity among patients with 
gastric carcinoma in the Indian subcontinent is similar to what is found in other parts 
of the world. 
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